Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

18.55
+0.72004.04%
Pre-market: 18.910.3600+1.94%04:09 EDT
Volume:424.05K
Turnover:7.75M
Market Cap:2.04B
PE:-7.24
High:18.62
Open:17.80
Low:17.43
Close:17.83
Loading ...
Apr 17, 2025

Major Issues Report

Form 8-K - Current report
Apr 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Correspondence

Form CORRESP - Correspondence
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Jan 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 10, 2024

Major Issues Report

Form 8-K - Current report
Dec 10, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Major Issues Report

Form 8-K - Current report